Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Oracle Cladribine in Early Multiple Sclerisis (MS) (ORACLE MS)
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Rituximab and multiple sclerosis.
One calcitriol dose transiently increases Helios(+)FoxP3(+) T cells and ameliorates autoimmune demyelinating disease.
A much-needed focus on progression in multiple sclerosis.
The challenge of comorbidity in clinical trials for multiple sclerosis.
Use of amiloride and multiple sclerosis: registry-based cohort studies.
Alemtuzumab benefits hard-to-treat MS patients
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Alemtuzumab for the Treatment of Multiple Sclerosis
Limit cycle oscillations in standing human posture.
Biogen Idec completes purchase of full rights and control of Tysabri®
Breastfeeding and multiple sclerosis.
Genzyme's Lemtrada™ Approved in Brazil for Treatment of Multiple Sclerosis
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b.
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Focal vibration in neurorehabilitation.
Pages
« first
‹ previous
…
62
63
64
65
66
67
68
69
70
…
next ›
last »
